Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model
Open Access
- 19 June 2007
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 97 (2) , 194-200
Abstract
Four-coordinate (Pt(II)) platinum-based anticancer drugs are widely used in primary or palliative chemotherapy and produce considerable efficacy in certain clinical applications, for example testicular cancer. However, in many cancers the Pt(II) drugs are beset by poor efficacy mainly due to suboptimal pharmacokinetic properties. Consequently, the six-coordinate (Pt(IV)) class of Pt drugs were developed to improve platinum efficacy by (i) increasing stability, (ii) reducing reactivity, (iii) increasing lipophilicity, and (iv) nuclear targeting. However, comparatively little information is available on the pharmacokinetic properties of these compounds within solid tumour tissue. In the present study, the distribution and fluxes of [14C]-labelled [PtCl2(en)] (where en stands for ethane-1,2-diamine) and cis,trans-[PtCl2(OH)2(en)] drugs were determined in the multicell layer (MCL) tumour model comprising colon cancer cells. Flux data were analysed by mathematical modelling of drug diffusion and cellular uptake in the transport system. The flux of the Pt(IV) compound through the MCL was not significantly different to that of the Pt(II) drug nor were the diffusion coefficient or tissue uptake; the latter confirmed with elemental imaging analysis by synchrotron radiation induced X-ray emission. However, the flux of the Pt(IV) through the MCL was increased by hydrostatic pressure, thereby demonstrating the potential to target cancer cells further away from the vessels with six-coordinate platinum drugs.Keywords
This publication has 21 references indexed in Scilit:
- Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: Experimental and mathematical modellingEuropean Journal of Cancer, 2006
- The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexesBiochemical Pharmacology, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Distribution and subcellular localization of a water-soluble hematoporphyrin–platinum(II) complex in human bladder cancer cellsCancer Letters, 2004
- The mechanism of action of platinum(IV) complexes in ovarian cancer cell linesJournal of Inorganic Biochemistry, 2004
- Cisplatin Rapidly Down-regulates Its Own Influx Transporter hCTR1 in Cultured Human Ovarian Carcinoma CellsClinical Cancer Research, 2004
- A library for X-ray–matter interaction cross sections for X-ray fluorescence applicationsSpectrochimica Acta Part B: Atomic Spectroscopy, 2004
- High interstitial fluid pressure — an obstacle in cancer therapyNature Reviews Cancer, 2004
- Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma CellsClinical Cancer Research, 2004
- XANES Determination of the Platinum Oxidation State Distribution in Cancer Cells Treated with Platinum(IV) Anticancer AgentsJournal of the American Chemical Society, 2003